Filter
10
Featured
Language
Document type
Videos
4
Resource Platforms
2
Manuals
1
Training Material
1
App
1
Fact sheets
1
Countries / Regions
Global
1
Latin America and the Carribbean
1
South–East Asia Region
1
Authors & Publishers
Drugs for Neglected Diseases initiative DNDi
4
Center for Disease Control and Prevention CDC
1
Kita, K.
1
Nagasaki University School of Tropical Medicine and Global Health
1
Pan American Health Organisation PAHO
1
World Health Organisation (WHO)
1
World Health Organisation WHO
1
World Health Organization WHO
1
Yamada, H.
1
Publication Years
Category
Dermatology
1
Vector Control
1
Guidelines
1
Leishmaniasis
1
Toolboxes
Recognizing neglected tropical diseseases through changes on the skin. App for Android and IOS, free of charge. The App is available in English and French, with plans to explore translations into other languages, such as Portuguese and Spanish, to better serve diverse communities. A patient's skin... more
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for... more
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti... more
The term leishmaniasis encompasses multiple clinical syndromes, including the cutaneous, mucosal, and visceral forms, which result from infection of macrophages in the dermis, in the naso-orpharyngeal mucosa, and throughout the reticuloendothelial system, respectively. The infection can range from a... more
Leishmaniasis is among the most neglected diseases. The most common form is cutaneous leishmaniasis that forms lesions on the skin. The only treatment available for cutaneous leishmaniasis is highly toxic. In some cases, patients have died because of the treatment, even though cutaneous leishmania... more

Webinar on Cutaneous Leishmaniasis and the summary of the proceedings

Yamada, H.; Kita, K. Nagasaki University School of Tropical Medicine and Global Health (2016) CC
Cutaneous Leishmaniasis (CL) is a painful disease that exerts a serious toll on societies around the world that are afflicted by it. Although not life-threatening, the skin ulcers and scars it causes can lead to isolation and psychosocial pathologies due to social stigma, and its occurrence is often... more
1 billion people are at risk of infection with leishmaniasis, a neglected disease strongly linked to poverty. There’s no single, simple cure: current treatments are complex and need to be adapted to the form of the disease and geographical region.
The Leishmaniasis East Africa Platform (LEAP) was established to support the generation of scientific evidence for the development and distribution of new treatments for leishmaniasis in Eastern Africa.
There are 3 main forms of leishmaniases: visceral (the most serious form because it is almost always fatal without treatment), cutaneous (the most common, usually causing skin ulcers), and mucocutaneous (affecting mouth, nose and throat). Leishmaniasis is caused by protozoan parasites which are tra... more
Cutaneous leishmaniasis is a painful disease that exerts a serious toll on societies around the world that are afflicted by it. Although not life-threatening, the skin ulcers and scars it causes can lead to isolation and psychosocial pathologies due to social stigma, and its occurrence is often asso... more